BTMD biote
- 6.030
- -0.080-1.31%
- 6.030
- 0.0000.00%
biote News
TD Cowen Maintains Biote(BTMD.US) With Buy Rating, Maintains Target Price $7
TD Cowen analyst Jonna Kim maintains $biote(BTMD.US)$ with a buy rating, and maintains the target price at $7.According to TipRanks data, the analyst has a success rate of 41.2% and a total average
Analysts Are Bullish on These Healthcare Stocks: Biote (BTMD), Ardent Health Partners, Inc. (ARDT)
Earnings Call Summary | Biote(BTMD.US) Q2 2024 Earnings Conference
Biote Corp. (BTMD) Q2 2024 Earnings Call Transcript
10-Q: Q2 2024 Earnings Report
Biote Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 EPS Results.
Truist Financial Gives a Buy Rating to Biote (BTMD)
BIOTE Reports Q2 GAAP EPS of -$0.19
Zacks.com Featured Highlights Include Steelcase Carriage Services, Biote and Acme United
Express News | Biote Corp : Jefferies Raises Target Price to $9.94 From $8.33
Express News | Biote Corp: Reiterates 2024 Financial Guidance
Earnings Flash (BTMD) BIOTE Reports Q2 Revenue $49.2M, Vs. Street Est of $49.1M
Express News | Biote Q2 Operating Income USD 6.2 Million Vs. IBES Estimate USD 8.65 Million
Express News | Biote Q2 Adjusted Ebitda USD 12.7 Million Vs. IBES Estimate USD 14.3 Million
Express News | Biote Q2 Gross Margin 68.9%
Express News | Biote Q2 Revenue USD 49.2 Million Vs. IBES Estimate USD 49.1 Million
Express News | Biote Reports Second Quarter 2024 Financial Results
Express News | Biote Q2 Adjusted Ebitda Margin 25.9%
Buy These 4 Stocks With Rising Cash Flows for Big Gains
Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call
Analysis
Price Target
No Data
No Data